Depression in pediatric patients with type 1 diabetes

Jennifer A. Tilleman, Edward M. DeSimone, Elizabeth Scheffel

Research output: Contribution to specialist publicationArticle

Abstract

Depression in pediatric patients with type 1 diabetes (T1D) is a growing area of discussion. A diagnosis of T1D requires pediatric patients and their families to make drastic lifestyle changes. Improper coping skills can negatively affect the patient’s life and jeopardize overall health, as signaled by poor glycemic control and A1C readings. The mainstay of treatment for depression in pediatric patients with T1D is psychotherapy. Medication is warranted in certain cases, and currently only two agents have FDA indications for pediatric depression: fluoxetine and escitalopram. The use of antidepressants in pediatric patients with T1D requires thorough counseling by a pharmacist to ensure optimal outcomes.

Original languageEnglish (US)
Pages27-30
Number of pages4
Volume41
No5
Specialist publicationU.S. Pharmacist
StatePublished - May 2016

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmaceutical Science

Cite this

Tilleman, J. A., DeSimone, E. M., & Scheffel, E. (2016). Depression in pediatric patients with type 1 diabetes. U.S. Pharmacist, 41(5), 27-30.